cysteine has been researched along with Carcinoma, Papillary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Fu, Y; Ge, X; Guo, H; Hu, Z; Li, M; Li, X; Meng, L; Qian, X; Shi, Z; Yin, J; Zhao, N; Zhao, X | 1 |
1 other study(ies) available for cysteine and Carcinoma, Papillary
| Article | Year |
|---|---|
Fumarate inhibits PTEN to promote tumorigenesis and therapeutic resistance of type2 papillary renal cell carcinoma.
Topics: Carcinogenesis; Carcinoma, Papillary; Carcinoma, Renal Cell; Cysteine; Drug Resistance, Neoplasm; Fumarate Hydratase; Fumarates; Humans; Kidney Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Sunitinib | 2022 |